Patent · US Expired

Pyrimidine, pyrazine and triazane derivatives

US6673795B2 · kind B2 · utility

1Cited by
0References
38Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMay 29, 2002
Grant dateJan 6, 2004
Priority date
Expiry dateMay 29, 2022

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D401/14
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention is a pyrimidine, triazine or pyrazine derivative of the formula or a pharmaceutically acceptable salt thereof wherein R1, R2, R3, R4, X, Y and Z are as defined in the specification. The invention is a pharmaceutical composition containing an effective amount of the compound of formula 1, its preparation and to a method of treatment, control or prevention of acute and/or chronic neurological disorders by administering a therapeutically effective amount of a compound of formula 1.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.